Identification and selection of potential TNF-α inhibitors as anti-encephalitis candidates by using in silico assisted drug design

Abstract Background Encephalitis, an inflammatory disorder of the brain caused by infections or autoimmune responses, is still a major global health concern due to its high morbidity, mortality, and long-term neurological consequences. The available therapy alternatives are usually confined, and con...

Full description

Saved in:
Bibliographic Details
Main Authors: Pawan Kumar Gupta, Shashi Bhooshan Tiwari
Format: Article
Language:English
Published: Springer 2025-06-01
Series:Discover Chemistry
Subjects:
Online Access:https://doi.org/10.1007/s44371-025-00226-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850111648505790464
author Pawan Kumar Gupta
Shashi Bhooshan Tiwari
author_facet Pawan Kumar Gupta
Shashi Bhooshan Tiwari
author_sort Pawan Kumar Gupta
collection DOAJ
description Abstract Background Encephalitis, an inflammatory disorder of the brain caused by infections or autoimmune responses, is still a major global health concern due to its high morbidity, mortality, and long-term neurological consequences. The available therapy alternatives are usually confined, and conventional drug discovery procedures are both resource-intensive and time-consuming. These challenges underscore the critical need for novel tools to speed up therapy development, which could revolutionize treatment regimens and enhance results for impacted people globally. Objective To identify, optimize & selection of TNF-α inhibitors as anti-encephalitis candidates by using in silico assisted drug design approach. Method Computer-aided drug design (CADD) is a revolutionize tool for identifying potential anti-encephalitis candidates through its ability to simulate molecular interactions, predict drug-target affinities, and optimize pharmacokinetic properties with molecular dynamics simulation. In this study, we have employed comprehensive in silico method to find effective therapeutic compounds that targets the TNF-α receptor in encephalitis. Result An in silico screening of nearly 600 isatin derivatives were conducted by using data from the PubChem database. It was carried out using the Lipinski rule of five in addition to other criteria. After filtering, 48 Isatin derivatives were selected, and six compounds with binding affinities exceeding −8.0 kcal/mol were identified as potential candidates. Additionally it was subjected to ADME analysis using Swiss ADME software. Every contender demonstrated greater binding affinity and actively crossed the BBB. Protein–ligand complexes were subjected to molecular dynamics (MD) simulations using CABS-flexV2.0 and the iMOD server in order to assess the root-mean-square fluctuations (RMSFs) and quantify protein stability respectively. Conclusion Hence, it is concluded that compounds with higher binding affinity and actively cross BBB values showed effective anti-encephalitis agents. We have performed molecular docking studies, ADMET analysis and MD simulation of all selected compounds and found that compounds G5, G17, G48, G15, G3 and G18 have showed better binding score against TNF-α in contrast to standard drug Acyclovir.
format Article
id doaj-art-e9ec3a4afa0b4588ac416635327c5b65
institution OA Journals
issn 3005-1193
language English
publishDate 2025-06-01
publisher Springer
record_format Article
series Discover Chemistry
spelling doaj-art-e9ec3a4afa0b4588ac416635327c5b652025-08-20T02:37:35ZengSpringerDiscover Chemistry3005-11932025-06-012112010.1007/s44371-025-00226-8Identification and selection of potential TNF-α inhibitors as anti-encephalitis candidates by using in silico assisted drug designPawan Kumar Gupta0Shashi Bhooshan Tiwari1Department of Pharmacy, Mahatma Jyotiba Phule Rohilkhand UniversityDepartment of Pharmacy, Mahatma Jyotiba Phule Rohilkhand UniversityAbstract Background Encephalitis, an inflammatory disorder of the brain caused by infections or autoimmune responses, is still a major global health concern due to its high morbidity, mortality, and long-term neurological consequences. The available therapy alternatives are usually confined, and conventional drug discovery procedures are both resource-intensive and time-consuming. These challenges underscore the critical need for novel tools to speed up therapy development, which could revolutionize treatment regimens and enhance results for impacted people globally. Objective To identify, optimize & selection of TNF-α inhibitors as anti-encephalitis candidates by using in silico assisted drug design approach. Method Computer-aided drug design (CADD) is a revolutionize tool for identifying potential anti-encephalitis candidates through its ability to simulate molecular interactions, predict drug-target affinities, and optimize pharmacokinetic properties with molecular dynamics simulation. In this study, we have employed comprehensive in silico method to find effective therapeutic compounds that targets the TNF-α receptor in encephalitis. Result An in silico screening of nearly 600 isatin derivatives were conducted by using data from the PubChem database. It was carried out using the Lipinski rule of five in addition to other criteria. After filtering, 48 Isatin derivatives were selected, and six compounds with binding affinities exceeding −8.0 kcal/mol were identified as potential candidates. Additionally it was subjected to ADME analysis using Swiss ADME software. Every contender demonstrated greater binding affinity and actively crossed the BBB. Protein–ligand complexes were subjected to molecular dynamics (MD) simulations using CABS-flexV2.0 and the iMOD server in order to assess the root-mean-square fluctuations (RMSFs) and quantify protein stability respectively. Conclusion Hence, it is concluded that compounds with higher binding affinity and actively cross BBB values showed effective anti-encephalitis agents. We have performed molecular docking studies, ADMET analysis and MD simulation of all selected compounds and found that compounds G5, G17, G48, G15, G3 and G18 have showed better binding score against TNF-α in contrast to standard drug Acyclovir.https://doi.org/10.1007/s44371-025-00226-8TNF-αMolecular dockingAnti-encephalitisIsatinCADD
spellingShingle Pawan Kumar Gupta
Shashi Bhooshan Tiwari
Identification and selection of potential TNF-α inhibitors as anti-encephalitis candidates by using in silico assisted drug design
Discover Chemistry
TNF-α
Molecular docking
Anti-encephalitis
Isatin
CADD
title Identification and selection of potential TNF-α inhibitors as anti-encephalitis candidates by using in silico assisted drug design
title_full Identification and selection of potential TNF-α inhibitors as anti-encephalitis candidates by using in silico assisted drug design
title_fullStr Identification and selection of potential TNF-α inhibitors as anti-encephalitis candidates by using in silico assisted drug design
title_full_unstemmed Identification and selection of potential TNF-α inhibitors as anti-encephalitis candidates by using in silico assisted drug design
title_short Identification and selection of potential TNF-α inhibitors as anti-encephalitis candidates by using in silico assisted drug design
title_sort identification and selection of potential tnf α inhibitors as anti encephalitis candidates by using in silico assisted drug design
topic TNF-α
Molecular docking
Anti-encephalitis
Isatin
CADD
url https://doi.org/10.1007/s44371-025-00226-8
work_keys_str_mv AT pawankumargupta identificationandselectionofpotentialtnfainhibitorsasantiencephalitiscandidatesbyusinginsilicoassisteddrugdesign
AT shashibhooshantiwari identificationandselectionofpotentialtnfainhibitorsasantiencephalitiscandidatesbyusinginsilicoassisteddrugdesign